A multicenter, randomized, evaluator blinded, active-controlled study to evaluate the safety and efficacy of oral SCY-078 vs. oral fluconazole in 96 subjects with moderate to severe vulvovaginal candidiasis

被引：7
|
作者：
Helou, S. [1 ]
Angulo, D. [1 ]
机构：
[1] Scynexis Inc, Jersey City, NJ USA
来源：
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 2017年 / 217卷 / 06期
关键词：
D O I：
10.1016/j.ajog.2017.08.099
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
19
引用
收藏
页码：720 / 721
页数：5
相关论文
共 29 条
  • [1] The efficacy and safety of clotrimazole vaginal tablet vs. oral fluconazole in treating severe vulvovaginal candidiasis
    Zhou, Xiaofang
    Li, Ting
    Fan, Shangrong
    Zhu, Yuxia
    Liu, Xiaoping
    Guo, Xuedong
    Liang, Yiheng
    [J]. MYCOSES, 2016, 59 (07) : 419 - 428
  • [2] Oral ibrexafungerp efficacy and safety in the treatment of vulvovaginal candidiasis: A phase 3, randomized, blinded, study vs. placebo (VANISH303)
    Schwebke, J. R.
    Sorkin-Wells, V.
    Azie, N.
    Angulo, D.
    Sobel, J.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 223 (06) : 964 - 965
  • [3] Efficacy and Safety of Oral Ibrexafungerp in Subjects with Vulvovaginal Candidiasis: Pooled Data from Two Phase 3, Randomized, Blinded, Study vs. Placebo (VANISH-303 and VANISH-306)
    Sobe, Jack
    Nyirjesy, Paul
    Falcon, Ron
    Azie, Nkechi
    Chen, Thomas
    Angulo, David
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2022, 226 (02) : 290 - 290
  • [4] A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oteseconazole (VT-1161) Oral Capsules in the Treatment of Subjects with Recurrent Vulvovaginal Candidiasis (VIOLET)
    Person, Karen
    Brand, Stephen
    Degenhardt, Thorsten
    Curelop, Stacey
    Sobel, Jack
    Donders, Gilbert
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2022, 226 (02) : 292 - 292
  • [5] A phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of once monthly oral ibrexafungerp for prevention of recurrent vulvovaginal candidiasis (VVC)
    Goje, O.
    Azie, N.
    King, T.
    Angulo, D.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2023, 228 (02) : S771 - S771
  • [6] Efficacy and Safety of a Novel Botulinum Toxin Type A Product for the Treatment of Moderate to Severe Glabellar Lines: A Randomized, Double-Blind, Active-Controlled Multicenter Study
    Won, Chong H.
    Lee, Hyung M.
    Lee, Woo S.
    Kang, Hoon
    Kim, Beom J.
    Kim, Won S.
    Lee, Ju H.
    Lee, Dong H.
    Huh, Chang H.
    [J]. DERMATOLOGIC SURGERY, 2013, 39 (01) : 171 - 178
  • [7] A Multicenter, Randomized, Observer-blinded, Active-controlled Study to Evaluate the Safety and Efficacy of Ceftaroline Versus Comparator in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infection
    Korczowski, Bartosz
    Antadze, Tinatin
    Giorgobiani, Manana
    Stryjewski, Martin E.
    Jandourek, Alena
    Smith, Alexander
    O'Neal, Tanya
    Bradley, John S.
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2016, 35 (08) : E239 - E247
  • [8] Efficacy and safety of a novel botulinum toxin type A product for the treatment of moderate to severe glabellar lines: A randomized, double-blinded, active controlled multicenter study
    Lee, W. S.
    Won, C. H.
    Huh, C. H.
    Kang, H.
    Kim, B. J.
    Lee, J. H.
    Kim, W. S.
    [J]. TOXICON, 2013, 68 : 116 - 116
  • [9] Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1)
    Barker, J.
    Hoffmann, M.
    Wozel, G.
    Ortonne, J. -P.
    Zheng, H.
    van Hoogstraten, H.
    Reich, K.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 (05) : 1109 - 1117
  • [10] Randomized, double-blind, active-controlled, multicentre, phase III clinical trial with two stages to assess the safety and efficacy of letibotulinum toxin a vs. onabotulinum toxin a for subjects with moderate to severe crow's feet
    Yoo, K. H.
    Park, S. J.
    Han, H. S.
    Won, C. H.
    Lee, Y. W.
    Kim, B. J.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (07) : 1587 - 1594
123